A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis
- Conditions
- Acute GastroenteritisNorovirus Acute Gastroenteritis
- Interventions
- Biological: Placebo
- Registration Number
- NCT06592794
- Lead Sponsor
- ModernaTX, Inc.
- Brief Summary
The primary objectives of this study are to evaluate the safety and reactogenicity of mRNA-1403, and to demonstrate the efficacy of mRNA-1403 to prevent protocol-defined moderate or severe norovirus acute gastroenteritis (AGE) associated with vaccine matched genotypes.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 25000
-
Participants who understand and are willing and physically able to comply with protocol mandated follow-up, including all procedures as assessed by the Investigator, and who are primarily responsible for their self-care and activities of daily living.
-
Participants may have chronic medical diagnoses but should be medically stable as assessed by the following criteria:
- Absence of medical events associated with underlying diagnoses and qualifying as SAEs within 1 month prior to study intervention on Day 1.
- Absence of known, current, and life-limiting diagnoses, which could continue for the duration of the study and which, in the opinion of the Investigator, would make completion of the protocol unlikely.
-
Capable of giving signed informed consent, which includes compliance with the requirements and restrictions listed in the informed consent form (ICF) and in the protocol.
-
Participants assigned female at birth are eligible to participate if they are not pregnant or breastfeeding/chestfeeding/bodyfeeding and meet protocol defined criteria.
- Participant is acutely ill or febrile (temperature ≥38.0 degrees Celsius (°C) [100.4 degrees Fahrenheit [°F]) 72 hours prior to or at the Screening Visit or Day 1.
- History of AGE within 14 days prior to Day 1 or close contact with an individual with AGE symptoms (in the home, socially, or occupationally) within 14 days prior to Day 1.
- History of a diagnosis or condition that in the judgment of the Investigator, is clinically unstable or may affect participant safety, assessment of safety endpoints, assessment of immune response, or adherence to study procedures.
- Current diagnosis of chronic gastrointestinal (GI) disease that is associated with ongoing symptoms of regular vomiting and/or diarrhea. Participants with stable, well-controlled chronic GI disease without regular vomiting and/or diarrhea can be considered for enrollment.
- Has a medical, psychiatric, or occupational condition that may pose additional risk as a result of participation or that could interfere with safety assessments or interpretation of results according to the investigator's judgment.
- Has undergone surgical procedures within 7 days prior to Day 1 or is scheduled to undergo a surgical procedure within 28 days after study intervention.
- Reported history of congenital or acquired immunodeficiency, immunocompromising/immunosuppressive condition, asplenia, or recurrent severe infections per protocol.
- Reported history of anaphylaxis, urticaria, or other significant AR requiring medical intervention after receipt of a vaccine or intervention that includes one or more of the same components contained in the study vaccine.
- History of myocarditis, pericarditis, or myopericarditis with onset within 180 days prior to Day 1 whose values have not returned to Baseline clinical status.
- History of Guillain-Barré syndrome.
- Reported history of coagulopathy or bleeding disorder considered a contraindication to IM injection or phlebotomy.
- Dermatologic conditions that could affect local solicited AR assessments.
- Diagnosis of malignancy within the previous 2 years (excluding nonmelanoma skin cancer).
- Has received systemic immunosuppressive therapies for >14 days in total within 6 months prior to Day 1 (for corticosteroids ≥10 milligrams (mg)/day of prednisone equivalent) or is anticipating the need for immunosuppressive treatment at any time during participation in the study.
- Has received or plans to receive any licensed vaccine ≤28 days prior to or within 28 days after study intervention (Day 1), except for influenza vaccines, which may be given 14 days before or after receipt of a study intervention.
- Receipt of systemic immunoglobulins or blood products within 3 months prior to Day 1 or plans for receipt during the study.
- Has donated ≥450 mL of blood products within 28 days prior to Day 1 Visit or plans to donate blood products during the study.
- Participated in a clinical study with investigational treatment within 90 days prior to Day 1 (Baseline) based on the medical history interview or plans to do so while participating in this study. Participants may continue in prior interventional study follow-up activities, provided that it does not involve further investigational treatment and/or procedures that may affect safety and/or other study endpoints, and study participation does not result in a breach of either study protocol.
- Is working as, has worked as, or is an immediate family member or household member of study personnel, Sponsor personnel, or study site staff directly involved with the conduct of the study.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description mRNA-1403 mRNA-1403 Participants will receive a single injection of mRNA-1403 on Day 1. Placebo Placebo Participants will receive a single injection of mRNA-1403 matching placebo (0.9% sodium chloride solution) on Day 1.
- Primary Outcome Measures
Name Time Method Number of Participants with Solicited Local and Systemic Adverse Reactions (ARs) Day 1 up to Day 7 (7 days after study intervention) Number of Participants with Unsolicited Adverse Events (AEs) Day 1 up to Day 28 (28 days after study intervention) Number of Participants with Medically Attended Adverse Events (MAAEs) Day 1 through Day 181 Number of Participants with Serious Adverse Events (SAEs), AEs of Special Interest (AESIs), and AEs Leading to Study Withdrawal Day 1 through Day 730 Vaccine Efficacy (VE) of mRNA-1403 to Prevent First Occurrence of Protocol-defined Moderate or Severe AGE Associated with Vaccine Matched Genotypes Day 15 through Day 730
- Secondary Outcome Measures
Name Time Method Geometric Mean Fold Rise (GMFR) of HBGA-blocking Antibodies Titers Against Vaccine Matched Genotypes Day 1 and Day 29 Percentage of Participants with Seroresponse Based on HBGA-blocking Antibody Titer Day 29 GMT of Binding Antibody (bAb) Against Vaccine-matched NoV Genotypes Day 1 and Day 29 VE of mRNA-1403 to Prevent First Occurrence of Protocol-defined Severe AGE Associated with Vaccine Matched Genotypes Day 15 through Day 730 VE of mRNA-1403 to Prevent First Occurrence of Protocol-defined Norovirus (NoV) AGE of Any Severity Associated with Vaccine Matched Genotypes Day 15 through Day 730 VE of mRNA-1403 to Prevent First Occurrence of Protocol-defined Moderate or Severe AGE Associated with Any Genogroup I or II NoV Genotype Day 15 through Day 730 VE of mRNA-1403 to Prevent First Occurrence of Protocol-defined Severe AGE Associated with Any Genogroup I or II NoV Genotype Day 15 through Day 730 VE of mRNA-1403 to Prevent Any Occurrence of Medically Attended AGE Associated with Vaccine Matched Genotypes, as well as any Genogroup I or II NoV Genotype Day 15 through Day 730 VE of mRNA-1403 to Prevent Any Occurrence of AGE Hospitalizations Associated With Vaccine Matched Genotypes, as well as any Genogroup I or II NoV Genotype Day 15 through Day 730 VE of mRNA-1403 to Prevent Any Occurrence of Protocol-defined Moderate or Severe AGE Associated with Vaccine Matched Genotypes Day 15 through Day 730 VE of mRNA-1403 to Prevent Any Occurrence of Protocol-defined AGE of Any Severity Associated with Any Genogroup I or II NoV Genotype Day 15 through Day 730 Geometric Mean Titer (GMT) of Histo-blood Group Antigen (HBGA)-blocking Antibodies Titers Against Vaccine Matched Genotypes Day 1 and Day 29 GMFR of bAb Titers Day 1 and Day 29 Percentage of Participants with Seroresponse Based on bAb Titer Day 29
Trial Locations
- Locations (271)
Centricity Research Mirabel
🇨🇦Mirabel, Canada
Accel Research Sites - Achieve Clinical Research
🇺🇸Birmingham, Alabama, United States
Cullman Clinical Trials
🇺🇸Cullman, Alabama, United States
Alliance for Multispecialty Research, LLC
🇺🇸Daphne, Alabama, United States
ClinMed, LLC
🇺🇸Phoenix, Arizona, United States
DM Clinical - Phoenix
🇺🇸Phoenix, Arizona, United States
HOPE Research Institute
🇺🇸Phoenix, Arizona, United States
Abby's Research Institute
🇺🇸Phoenix, Arizona, United States
Headlands Research Scottsdale
🇺🇸Scottsdale, Arizona, United States
Scottsdale Clinical Trials
🇺🇸Scottsdale, Arizona, United States
Hope Research Institute - Tempe
🇺🇸Tempe, Arizona, United States
Arizona Liver Health
🇺🇸Tucson, Arizona, United States
Quality of Life Medical and Research Center
🇺🇸Tucson, Arizona, United States
Del Sol Research Management LLC.- Tucson
🇺🇸Tucson, Arizona, United States
Lynn Institute of the Ozarks
🇺🇸Little Rock, Arkansas, United States
Baptist Health Center for Clinical Research
🇺🇸Little Rock, Arkansas, United States
ARK Clinical Research, LLC
🇺🇸Fountain Valley, California, United States
ASCADA Research, LLC - Family Medicine
🇺🇸Fullerton, California, United States
Matrix Clinical Research
🇺🇸Los Angeles, California, United States
Velocity Clinical Research, San Diego
🇺🇸La Mesa, California, United States
Ark Clinical Research
🇺🇸Long Beach, California, United States
Velocity Clinical Research - Westlake
🇺🇸Los Angeles, California, United States
Paradigm Research
🇺🇸Redding, California, United States
Artemis Institute for Clinical Research
🇺🇸San Diego, California, United States
Benchmark Research
🇺🇸Fort Worth, Texas, United States
Peninsula Research Associates (PRA)
🇺🇸Rolling Hills Estates, California, United States
Apex Clinical Research
🇺🇸San Diego, California, United States
Lynn Institute of Denver
🇺🇸Aurora, Colorado, United States
Tekton Research - Fort Collins
🇺🇸Fort Collins, Colorado, United States
Tekton Research, Inc - Longmont Center
🇺🇸Longmont, Colorado, United States
Imagine Research of Palm Beach County
🇺🇸Boynton Beach, Florida, United States
Pioneer Clinical Studies
🇺🇸Coral Gables, Florida, United States
Integrity Clinical Research, LLC (ICR SITES) - Doral
🇺🇸Doral, Florida, United States
Alliance for multispecialty Research - Florida
🇺🇸Doral, Florida, United States
AGA Clinical Trials
🇺🇸Hialeah, Florida, United States
Best Quality Research Inc.
🇺🇸Hialeah, Florida, United States
Neoclinical Research
🇺🇸Hialeah, Florida, United States
Research Centers of America
🇺🇸Hollywood, Florida, United States
Nature Coast Clinical Research, LLC - Inverness
🇺🇸Inverness, Florida, United States
Westside Center for Clinical Research
🇺🇸Jacksonville, Florida, United States
Clinical Neuroscience Solutions, Inc
🇺🇸Orlando, Florida, United States
Health Awareness INC
🇺🇸Jupiter, Florida, United States
University Clinical Research- Deland
🇺🇸Lake Mary, Florida, United States
Meridien Research
🇺🇸Lakeland, Florida, United States
Clinical Site Partners - Leesburg
🇺🇸Leesburg, Florida, United States
Accel Clinical Research - Maitland
🇺🇸Maitland, Florida, United States
Dade Research Center, LLC
🇺🇸Miami, Florida, United States
Miami Clinical Research
🇺🇸Miami, Florida, United States
Universal Axon Clinical Research
🇺🇸Miami, Florida, United States
Florida International Research Center
🇺🇸Miami, Florida, United States
Suncoast Research Associates, LLC
🇺🇸Miami, Florida, United States
Miami Dade Medical Research Institute, LLC
🇺🇸Miami, Florida, United States
Felicidad Medical Research
🇺🇸Miami, Florida, United States
Aqualane Clinical Research
🇺🇸Naples, Florida, United States
SUNCOAST Clinical Research
🇺🇸New Port Richey, Florida, United States
Clinical Research Center of Florida
🇺🇸Pompano Beach, Florida, United States
United Medical Research
🇺🇸Port Orange, Florida, United States
Health Awareness, Inc
🇺🇸Port Saint Lucie, Florida, United States
St. Johns Center for Clinical Research
🇺🇸Saint Augustine, Florida, United States
IMA Clinical Research - St. Petersburg
🇺🇸Saint Petersburg, Florida, United States
Global Clinical Professionals, LLC
🇺🇸Saint Petersburg, Florida, United States
Precision Clinical Research, LLC
🇺🇸Sunrise, Florida, United States
Albany Internal Medicine
🇺🇸Albany, Georgia, United States
Delricht Research At Springer Wellness And Restorative Health
🇺🇸Atlanta, Georgia, United States
Atlanta Center for Medical Research
🇺🇸Atlanta, Georgia, United States
CenExel iResearch Atlanta, LLC
🇺🇸Decatur, Georgia, United States
Javara Inc.
🇺🇸Fayetteville, Georgia, United States
Fellows Research Alliance, Inc.
🇺🇸Savannah, Georgia, United States
Velocity Clinical Research-Savannah
🇺🇸Savannah, Georgia, United States
Clinical Research Atlanta/Headlands
🇺🇸Stockbridge, Georgia, United States
Clinical Research Prime
🇺🇸Idaho Falls, Idaho, United States
Velocity Clinical Research - Boise
🇺🇸Meridian, Idaho, United States
IMA Clinical Research
🇺🇸San Antonio, Texas, United States
Great Lakes Clinical Trials - Gurnee
🇺🇸Gurnee, Illinois, United States
Bioluminix Clinical Research Chicago
🇺🇸Naperville, Illinois, United States
Optimal Research
🇺🇸Peoria, Illinois, United States
DM Clinical Research- River Forest
🇺🇸River Forest, Illinois, United States
Velocity Clinical Research - Valparaiso
🇺🇸Valparaiso, Indiana, United States
Velocity Clinical Research-Sioux City
🇺🇸Sioux City, Iowa, United States
Johnson County Clin-Trials (JCCT)
🇺🇸Lenexa, Kansas, United States
Velocity Clinical Research- Kansas City
🇺🇸Overland Park, Kansas, United States
Tekton Research
🇺🇸Wichita, Kansas, United States
AMR Lexington
🇺🇸Lexington, Kentucky, United States
Velocity Clinical Research - Baton Rouge
🇺🇸Baton Rouge, Louisiana, United States
Velocity Clinical Research - Covington
🇺🇸Covington, Louisiana, United States
Clinical Trials Management, LLC
🇺🇸Metairie, Louisiana, United States
Privia Medical Group
🇺🇸Annapolis, Maryland, United States
Cenexel CBH (CBH Health)
🇺🇸Gaithersburg, Maryland, United States
Velocity Clinical Research-Rockville
🇺🇸Rockville, Maryland, United States
Javara Inc/Privia Medical Group, LLC
🇺🇸Silver Spring, Maryland, United States
DM Clinical Research - Brookline
🇺🇸Brookline, Massachusetts, United States
Skylight Health Research - Burlington
🇺🇸Burlington, Massachusetts, United States
Headlands Research - Detroit
🇺🇸Southfield, Michigan, United States
Great Lakes Research Institute
🇺🇸Southfield, Michigan, United States
DM Clinical Research - Southfield
🇺🇸Southfield, Michigan, United States
Oakland Medical Research Center
🇺🇸Troy, Michigan, United States
Clinical Research Institute, Inc.
🇺🇸Minneapolis, Minnesota, United States
Velocity Clinical Research, Gulfport
🇺🇸Gulfport, Mississippi, United States
Clinical Research Professionals
🇺🇸Chesterfield, Missouri, United States
Clinvest Headlands LLC
🇺🇸Springfield, Missouri, United States
Delricht Research
🇺🇸Springfield, Missouri, United States
Montana Medical Research, Inc
🇺🇸Missoula, Montana, United States
Velocity Clinical Research-Lincoln
🇺🇸Lincoln, Nebraska, United States
Velocity Clinical Research-Norfolk
🇺🇸Norfolk, Nebraska, United States
Velocity Clinical Research-Omaha
🇺🇸Omaha, Nebraska, United States
Javara Inc. / Nevada Health Centers, Ind
🇺🇸Carson City, Nevada, United States
Vector Clinical Trials
🇺🇸Las Vegas, Nevada, United States
Oasis Clinical Research
🇺🇸Las Vegas, Nevada, United States
DM Clinical Research - New Jersey
🇺🇸Jersey City, New Jersey, United States
IMA Clinical Research Warren
🇺🇸Warren, New Jersey, United States
Albuquerque Clinical Trials (ACT)
🇺🇸Albuquerque, New Mexico, United States
DM Clinical Research
🇺🇸Tomball, Texas, United States
Velocity Clinical Research- Albuquerque
🇺🇸Albuquerque, New Mexico, United States
Velocity Clinical Research - Binghamton
🇺🇸Binghamton, New York, United States
DM Clinical - Brooklyn
🇺🇸Brooklyn, New York, United States
Brooklyn Clinical Research
🇺🇸Brooklyn, New York, United States
Velocity Clinical Research - Syracuse
🇺🇸East Syracuse, New York, United States
Drug Trials America
🇺🇸Hartsdale, New York, United States
Rochester Clinical Research, Inc
🇺🇸Rochester, New York, United States
Velocity Clinical Research-Vestal
🇺🇸Vestal, New York, United States
DelRicht Research, LLC
🇺🇸Charlotte, North Carolina, United States
Javara Inc. - Tryon Medical-South Park
🇺🇸Charlotte, North Carolina, United States
Velocity Clinical Research, Durham
🇺🇸Durham, North Carolina, United States
West Clinical Research
🇺🇸Morehead City, North Carolina, United States
Accellacare Raleigh
🇺🇸Raleigh, North Carolina, United States
Accellacare of Wilmington
🇺🇸Wilmington, North Carolina, United States
Javara - Wake Forest University Health Sciences
🇺🇸Winston-Salem, North Carolina, United States
Velocity Clinical Research, Cleveland
🇺🇸Beachwood, Ohio, United States
Velocity Clinical Research-Mt. Auburn
🇺🇸Cincinnati, Ohio, United States
CTI Clinical Research Center
🇺🇸Cincinnati, Ohio, United States
Velocity Clinical Reseach - Blue Ash
🇺🇸Cincinnati, Ohio, United States
Velocity Clinical Research - Cincinnati OH
🇺🇸Cincinnati, Ohio, United States
Centricity Research
🇺🇸Columbus, Ohio, United States
Remington-Davis Clinical Research
🇺🇸Columbus, Ohio, United States
Tekton Research, Inc - Edmond
🇺🇸Edmond, Oklahoma, United States
Delricht Tate
🇺🇸Tulsa, Oklahoma, United States
Tekton Research, Inc - Yukon Location
🇺🇸Yukon, Oklahoma, United States
Altoona Center for Clinical Research - Research
🇺🇸Duncansville, Pennsylvania, United States
Velocity Clinical Research - Providence
🇺🇸East Greenwich, Rhode Island, United States
Velocity Clinical Research - Anderson
🇺🇸Anderson, South Carolina, United States
DelRicht Research
🇺🇸Charleston, South Carolina, United States
Coastal Carolina Research Center - North Charleston
🇺🇸North Charleston, South Carolina, United States
Velocity Clinical Research, Spartanburg
🇺🇸Spartanburg, South Carolina, United States
PMG Research of Bristol, LLC
🇺🇸Bristol, Tennessee, United States
Delricht Moyer
🇺🇸Hendersonville, Tennessee, United States
CNS Healthcare DBA Clinical Neuroscience Solutions, INC
🇺🇸Memphis, Tennessee, United States
IMA Clinical Research Austin
🇺🇸Austin, Texas, United States
Tekton Research, Inc. - Beaumont
🇺🇸Beaumont, Texas, United States
Headlands Research Brownsville
🇺🇸Brownsville, Texas, United States
Family Medicine Associates of Texas
🇺🇸Carrollton, Texas, United States
Javara Inc (Conroe)
🇺🇸Conroe, Texas, United States
WR-Global Medical Research, LLC
🇺🇸Dallas, Texas, United States
El Paso Research
🇺🇸El Paso, Texas, United States
West Houston Clinical Research Service
🇺🇸Houston, Texas, United States
DM Clinical Research - CyFair
🇺🇸Houston, Texas, United States
DM Clinical Research - Bellaire
🇺🇸Houston, Texas, United States
DM Clinical Research - Irving
🇺🇸Irving, Texas, United States
ACRC Trials
🇺🇸Plano, Texas, United States
Research Your Health
🇺🇸Plano, Texas, United States
Delricht Research At Zomnir Family Medicine
🇺🇸Prosper, Texas, United States
DM Clinical Research - San Antonio
🇺🇸San Antonio, Texas, United States
Tekton Research Inc - San Antonio
🇺🇸San Antonio, Texas, United States
DM Clinical Research - Sugarland
🇺🇸Sugar Land, Texas, United States
DM Clinical Research - Tomball
🇺🇸Tomball, Texas, United States
Cope Family Medicine
🇺🇸Bountiful, Utah, United States
JBR Clinical Research
🇺🇸Salt Lake City, Utah, United States
Charlottesville Medical Research Center, LLC
🇺🇸Charlottesville, Virginia, United States
Velocity Clinical Research - Hampton
🇺🇸Hampton, Virginia, United States
Health Research of Hampton Roads
🇺🇸Newport News, Virginia, United States
AMR Norfolk
🇺🇸Norfolk, Virginia, United States
Velocity Clinical Research-Portsmouth
🇺🇸Portsmouth, Virginia, United States
Clinical Research Partners, LLC
🇺🇸Richmond, Virginia, United States
DM Clinical Research - Seattle
🇺🇸Seattle, Washington, United States
Frontier Clinical Research, LLC
🇺🇸Kingwood, West Virginia, United States
Paratus Clinical Research Canberra
🇦🇺Bruce, Australian Capital Territory, Australia
Northside Health
🇦🇺Coffs Harbour, New South Wales, Australia
Momentum Clinical Research Darlinghurst
🇦🇺Darlinghurst, New South Wales, Australia
Paratus Clinical Research Central Coast
🇦🇺Kanwal, New South Wales, Australia
Paratus Clinical Research Brisbane
🇦🇺Herston, Queensland, Australia
Griffith University Hospital
🇦🇺Southport, Queensland, Australia
Fusion Clinical Research
🇦🇺Norwood, South Australia, Australia
Veritus Research
🇦🇺Bayswater, Victoria, Australia
Emeritus Research (Melbourne)
🇦🇺Camberwell, Victoria, Australia
The Peter Doherty Institute for Infection & Immunity
🇦🇺North Melbourne, Victoria, Australia
CARe Clinic
🇨🇦Calgary, Canada
Intermed Groupe Sante
🇨🇦Chicoutimi, Canada
Apex Trials
🇨🇦Guelph, Canada
Isaak Walton Killam Health Centre
🇨🇦Halifax, Canada
Okanagan Clinical Trials
🇨🇦Kelowna, Canada
Centricity Research Quebec City
🇨🇦Levis, Canada
Milestone Research Inc.
🇨🇦London, Canada
Centricity Research Pointe-Claire
🇨🇦Pointe-Claire, Canada
Centre de Recherche Saint-Louis
🇨🇦Quebec, Canada
Clinique Spécialisée en Allergie de la Capitale
🇨🇦Québec, Canada
CARe Clinic Red Deer
🇨🇦Red Deer, Canada
Richmond Clinical Trials
🇨🇦Richmond, Canada
Bluewater Clinical Research Group, Inc
🇨🇦Sarnia, Canada
Diex Research Sherbrooke Inc
🇨🇦Sherbrooke, Canada
Medicor Research Inc.
🇨🇦Sudbury, Canada
Centricity Research Toronto LMC
🇨🇦Toronto, Canada
Diex Recherche Trois-Rivières
🇨🇦Trois-Rivieres, Canada
Colchester Research Group
🇨🇦Truro, Canada
Chubu Rosai Hospital - Rheumatology & Collageous
🇯🇵Nagoya, Aichi, Japan
Daido clinic
🇯🇵Nagoya, Aichi, Japan
Medical Corporation JR Hiroshima Hospital
🇯🇵Hiroshima-shi, Hirosima [Hiroshima], Japan
Kotoni Medical Support Clinic
🇯🇵Sapporo, Hokkaidô [Hokkaido], Japan
Tenjin Sogo Clinic
🇯🇵Fukuoka-shi, Hukuoka [Fukuoka], Japan
Matsuba Clinic
🇯🇵Kawasaki-shi, Kanagawa, Japan
Hayashi-Katagihara Clinic
🇯🇵Kyoto-shi, Kyôto [Kyoto], Japan
Yokoi Medicine Clinic
🇯🇵Minoh, Osaka, Japan
Asano Clinic
🇯🇵Kawagoe-shi, Saitama, Japan
Omi Medical Center
🇯🇵Yabasecho, Shiga, Japan
Dojinkinenkai Meiwa Hospital
🇯🇵Chiyoda-ku, Tôkyô [Tokyo], Japan
Nihonbashi Sakura Clinic
🇯🇵Chuo-ku, Tôkyô [Tokyo], Japan
Medical Corporation Asbo Tokyo Asbo Clinic
🇯🇵Minato-Ku, Tôkyô [Tokyo], Japan
Tokyo Saiseikai Central Hospital
🇯🇵Minato-Ku, Tôkyô [Tokyo], Japan
Denenchofu Family Clinic
🇯🇵Ota, Tôkyô [Tokyo], Japan
Higashi-Shinjuku Clinic - Internal Medicine
🇯🇵Shinjuku-ku, Tôkyô [Tokyo], Japan
Shimamura Memorial Hospital
🇯🇵Suginami, Tôkyô [Tokyo], Japan
P-one Clinic
🇯🇵Hachioji, Tôkyô, Japan
Sasaki Clinic
🇯🇵Hyogo, Japan
NewHeart Watanabe Institute
🇯🇵Kanazawa-shi, Japan
Izumino Hospital
🇯🇵Kochi, Japan
Sapporo Odori Endoscopy Clinic
🇯🇵Sapporo-shi, Japan
Takatsuki General Hosiptal
🇯🇵Takatsuki-shi, Japan
CEVAXIN David
🇵🇦David, Chiriquí, Panama
CEVAXIN Avenida Mexico
🇵🇦Ciudad de Panamá, Panama
CEVAXIN Chorrera
🇵🇦La Chorrera, Panama
CEVAXIN 24 de Diciembre
🇵🇦Panama City, Panama
BRCR Global
🇵🇷Ponce, Puerto Rico
Clinical Research Puerto Rico, Inc.
🇵🇷San Juan, Puerto Rico
Research Works San Juan
🇵🇷San Juan, Puerto Rico
Velocity Clinical Research - High Wycombe
🇬🇧High Wycombe, Buckinghamshire, United Kingdom
Warrington and Halton Teaching Hospitals NHS Foundation Trust - Halton General Hospital
🇬🇧Runcorn, Cheshire, United Kingdom
Royal Cornwall Hospitals NHS Trust - Royal Cornwall Hospital
🇬🇧Truro, Cornwall, United Kingdom
St George's University Hospitals NHS Foundation Trust - St George's Hospital
🇬🇧London, England, United Kingdom
Accellacare South London
🇬🇧Orpington, Kent, United Kingdom
Layton Medical Centre
🇬🇧Blackpool, Lancashire, United Kingdom
Panthera Biopartners - Manchester
🇬🇧Rochdale, Manchester, United Kingdom
Northern Care Alliance NHS Foundation Trust - Salford Royal Hospital
🇬🇧Salford, Manchester, United Kingdom
Lakeside Healthcare
🇬🇧Corby, Northamptonshire, United Kingdom
Eynsham Medical Center
🇬🇧Witney, Oxfordshire, United Kingdom
NHS Grampian - Aberdeen Royal Infirmary
🇬🇧Aberdeen, United Kingdom
NIHR Welcome Trust Clinical Research Facility
🇬🇧Birmingham, United Kingdom
Bournemouth Research Hub
🇬🇧Bournemouth, United Kingdom
North Bristol NHS Trust - Southmead Hospital
🇬🇧Bristol, United Kingdom
Cardiff and Vale University Health Board - University Hospital Wales
🇬🇧Cardiff, United Kingdom
Accellacare Warwickshire Quality Research Site
🇬🇧Coventry, United Kingdom
NHS Lothian - Western General Hospital
🇬🇧Edinburgh, United Kingdom
Panthera Biopartners - North London
🇬🇧Enfield Town, United Kingdom
Royal Devon & Exeter Hospital (Wonford)
🇬🇧Exeter, United Kingdom
CPS Research by FutureMeds
🇬🇧Glasgow, United Kingdom
Glasgow Clinical Research Facility
🇬🇧Glasgow, United Kingdom
Panthera Biopartners - Glasgow
🇬🇧Glasgow, United Kingdom
University Hospitals of Leicester NHS Trust
🇬🇧Leicester, United Kingdom
FutureMeds Wirral
🇬🇧Liverpool, United Kingdom
Mile End Hospital
🇬🇧London, United Kingdom
Royal Free London NHS Foundation Trust - Royal Free Hospital
🇬🇧London, United Kingdom
Manchester University NHS Foundation Trust
🇬🇧Manchester, United Kingdom
FutureMeds Newcastle
🇬🇧Newcastle upon Tyne, United Kingdom
The Newcastle Upon Tyne Hospitals NHS Foundation Trust
🇬🇧Newcastle upon Tyne, United Kingdom
Leeds Teaching Hospitals NHS Trust - St James' University Hospital
🇬🇧Nottingham, United Kingdom
Plymouth Hospital NHS trust-Derriford Hospital
🇬🇧Plymouth, United Kingdom
Portsmouth Research Hub
🇬🇧Portsmouth, United Kingdom
Panthera Biopartners - Sheffield
🇬🇧Sheffield, United Kingdom
Accellacare Yorkshire Quality Research Site
🇬🇧Shipley, United Kingdom
Wansford Research Ltd
🇬🇧Wansford, United Kingdom
Weymouth Research Hub
🇬🇧Weymouth, United Kingdom
Windrush Medical Practice
🇬🇧Witney, United Kingdom
North Wales Clinical Research Centre (NWCRC)
🇬🇧Wrexham, United Kingdom
Panthera Biopartners - York
🇬🇧York, United Kingdom